Compare Funko Inc (FNKO) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Funko Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Funko Inc trades at $6.35 (market cap $365.09M), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 23.2× Funko Inc's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Funko Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Funko Inc for 33 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| FNKO | HNGE | |
|---|---|---|
Market Cap | $365.09M | $8.48B |
Volume | 435,098 | 879,799 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.10 | $105.14 |
52-Week Low | $2.81 | $31.17 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $585.74M | $8.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNKO trades at $6.35, down 1.7% today, with a bullish technical signal from moving averages despite overbought RSI readings. The company shows improving fundamentals with Q2 2026 earnings beating expectations, revenue growth of 7% year-over-year, and raised EBITDA guidance to $105 million. Analyst consensus is mixed with 42.9% buy ratings and a $7.58 price target, representing 19% upside potential from current levels.
Investment outlook remains cautiously optimistic as FNKO demonstrates operational improvements with margin expansion and debt reduction. Key risks include negative net income margins, volatile cash flow patterns, and competitive pressures in the collectibles market. The stock offers value with a low P/S ratio of 0.39x and attractive EV/EBITDA of 6.84x, but requires sustained profitability to justify further appreciation.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
